Bio-Inno
Latest round
- Series A
Last raised
- Jun 2026
Total raised
- Undisclosed
Investors
- 6
About Bio-Inno
, dba Bio-Inno, operates as an immunotherapy developer that provides mid- to late-stage immunotherapy for oncology, cancer diagnostics, and peptide drug development. In January 2022, the company signed a research cooperation agreement with Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology., Perfect Medical, Yuanmiao (Zhuhai Hengqin). The company's business integrates basic research, product development, production and sales. The main products are antibody reagents for auxiliary diagnosis, diagnostic reagents for immunohistochemistry, and peptide anti-thoracic fluid drugs. The company also provides clinical testing services. The company's two core products, PD-L1 concomitant diagnostic kit "Inocon", can improve the specificity of the test, and the new anti-tumor cell metastasis peptide "Inotec", which controls the problem of chest and abdominal fluid by inhibiting the activity and metastasis of cancer cells. The company generate revenue from providing diagnostic services for mid- to late-stage cancer immunotherapy.
Who invested in Bio-Inno
6 investors across 2 rounds
See all investors in Bio-Inno
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bio-Inno
Who invested in Bio-Inno?
Bio-Inno has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bio-Inno raised?
Bio-Inno has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Bio-Inno last raise money?
Bio-Inno's most recent round on record is a Series A, in Jun 2026.
What does Bio-Inno do?
, dba Bio-Inno, operates as an immunotherapy developer that provides mid- to late-stage immunotherapy for oncology, cancer diagnostics, and peptide drug development.
Where is Bio-Inno headquartered?
Bio-Inno is headquartered in Wuhan, China.
Which VCs invest in companies like Bio-Inno?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Bio-Inno's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Bio-Inno? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.